LEXICON PHARMACEUTICALS, INC. - COM NEW (LXRX)

Historical Portfolio Holders from Q2 2015 to Q2 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM NEW
Shares, excl. options Q1 2024: 172 M
Holdings value Q1 2024: $412 M
Value change Q1 2024: -$24.9 M
Grand Portfolio weight change Q1 2024: 0%
Number of holders: 114
Number of buys Q1 2024: 2
Number of sells Q1 2024: 0
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0
CUSIP: 528872302

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q2	34.6 K	$57.8 K	+$5.55 K			$1.68	3
2024 Q1	172 M	$412 M	-$24.9 M	988 K	5.06 M	$2.40	114
2023 Q4	183 M	$280 M	-$6.9 M	382 K	173 K	$1.53	102
2023 Q3	189 M	$206 M	-$5.56 M	237 K	78.4 K	$1.09	109
2023 Q2	191 M	$438 M	+$105 M	743 K	74.2 K	$2.29	119
2023 Q1	146 M	$354 M	-$2.97 M	229 K	320 K	$2.43	102
2022 Q4	147 M	$280 M	-$3.99 M	58.1 K	203 K	$1.91	101
2022 Q3	149 M	$357 M	+$72.5 M	54 K	132 K	$2.40	96
2022 Q2	119 M	$221 M	-$2.37 M	77 K	228 K	$1.86	82
2022 Q1	120 M	$251 M	-$5.49 M	38 K	102 K	$2.09	100
2021 Q4	121 M	$478 M	-$1.64 M	478 K	352 K	$3.94	107
2021 Q3	121 M	$582 M	+$17.5 M	283 K	562 K	$4.81	94
2021 Q2	118 M	$540 M	+$2.25 M	974 K	1.28 M	$4.59	104
2021 Q1	121 M	$711 M	+$169 K	1.12 M	1.8 M	$5.87	105
2020 Q4	122 M	$417 M	+$66.3 M	1.1 M	1.62 M	$3.42	102
2020 Q3	104 M	$150 M	-$5.06 M	146 K	237 K	$1.44	85
2020 Q2	107 M	$213 M	+$4.6 M	114 K	175 K	$1.99	96
2020 Q1	105 M	$204 M	-$17.1 M	133 K	235 K	$1.95	103
2019 Q4	107 M	$445 M	+$20.6 M	752 K	1.25 M	$4.15	109
2019 Q3	102 M	$308 M	-$29.7 M	1.12 M	878 K	$3.01	95
2019 Q2	105 M	$662 M	+$6.86 M	2.72 M	837 K	$6.29	106
2019 Q1	104 M	$579 M	-$5.05 M	4.9 M	1.18 M	$5.56	115
2018 Q4	105 M	$699 M	-$16.7 M	1.18 M	556 K	$6.64	117
2018 Q3	107 M	$1.15 B	-$15.9 M	2.85 M	2.92 M	$10.67	115
2018 Q2	104 M	$1.25 B	+$352 K	1.92 M	4.6 M	$12.00	115
2018 Q1	110 M	$940 M	-$14 M	1.33 M	450 K	$8.57	122
2017 Q4	111 M	$1.1 B	-$43.7 M	1.33 M	1.11 M	$9.88	125
2017 Q3	110 M	$1.36 B	-$5.81 M	12.2 M	1.74 M	$12.29	130
2017 Q2	110 M	$1.82 B	+$18.3 M	1.34 M	16 M	$16.45	128
2017 Q1	110 M	$1.58 B	+$120 M	3.79 M	2.01 M	$14.34	132
2016 Q4	106 M	$1.47 B	-$2.53 M	1.56 M	5.42 M	$13.83	140
2016 Q3	106 M	$1.92 B	-$587 K	3.71 M	6.86 M	$18.07	137
2016 Q2	106 M	$1.52 B	+$912 K	7.55 M	5.33 M	$14.35	131
2016 Q1	111 M	$1.32 B	+$13.9 M	3.26 M	3.53 M	$11.95	124
2015 Q4	110 M	$1.46 B	+$55.1 M	11.1 M	6.91 M	$13.31	115
2015 Q3	106 M	$1.14 B	+$98.4 M	895 K	10.9 M	$10.74	101
2015 Q2	96.8 M	$779 M	+$779 M			$8.05	86